Member Info for nashwan123

Also positive to hear Mo say institutions are also buying equity in HVO

Great looong awaited news. Problem is do Opti have the ability to manufacture Sweetbiotix?

If not then they need DSM-Firmenich to make and supply the product or another multinational. This could undermine the intrinsic value of this world leading sugar alternative and likewise revenues to Opti.

Carlin for President

Naïve as it may read but if Polb 001 has shown no safety issues and great efficacy, then why can’t it be trialled immediately?

It could save a whole lot of suffering now.

My take from last nights presentation was fairly positive. The investments bar one to be ditched are all gaining traction (customers). Device authority and Wylde leading the pack and appear to be front runners in their markets. Problem is they are all still going to need cash to upscale. So the Tern board are either going to persuade shareholders to pay up or see a dilution of their holdings. At least Sisto and Payne's influence has been reigned in.

Drug approval often takes an age. However I cannot see why POLB001 cannot be tested on cancer patients PDQ, as it has already been tested and shown to work with great efficacy and no discernible side effects. A no brainer!

After @ 20 years of being a TERN investor I feel sufficiently mugged, particularly by Al and Sarah, to sell my last holding at a thumping loss. Years of promise and delivery for shareholders is NIL.

Imagine if these two had appeared on Alan Sugar's 'Apprentice' he would have roasted them!

The reason I sold out some years ago was the perpetual awarding of free shares to directors. Good news today but will the sweets be dished out again at the expense of investors!

This sell off has got me thinking that Device Authority (Keyscaler)does not have credible security software to prevent ransomware attacks. If it has then the market should be fully switched on and talking non stop about DA. The SP would be north of 50p by now too.
Or can it be that the SP fall is all down to Al Sisto being blocked from raising funds?

entelon. First class reply and much appreciated. I perhaps got ahead of myself with the proposed use of Parsotix. I saw the possibility of it being rolled out for mass screening of any rogue cells. Say anyone over 60 could have an annual check with the opportunity of nipping progression in the bud. What a boon for society and our health service for cancer screening to become much more proactive. Clearly cancer is super complex with its ability to change cell development too and so not quite as simple to identify the right treatment. It seemed to me that costly and invasive biopsy surgery could be completely replaced and the cost benefit almost being neutral. Nonetheless this must be seen as a step change for clinicians.

Entelon I appreciate your most informed contribution. A question I have is why tissue biopsies will be required if Parsotix can identify rogue cells (CTCs) via a blood test?

Completely agree. Also no extra overheads so even more cash straight to the bottom line.

There are currently no open short positions in Zoetic Intl.

GMR SP began to rise during the last lock down as folk spent more time gaming online. The biggest danger to shareholder wealth is a takeover approach. I was in Ladbrokes and once they got into the USA they were taken out at a fraction of their future earnings.
Also worth rereading last September trading update which makes me believe GMR will be heading to 30p soon with the potential bonus of a dividend in 2021. the City will note GMR are EBITDA positive.

Since updating the market on 8 September 2020 when publishing its interim results, the Company is pleased to report that business performance and sales momentum has continued the trend demonstrated throughout the first 8 months of this year.

Revenues for the Period are expected to be GBP10.7m, 55% ahead of 2019. As a result of this increase in revenue, the Company expects adjusted EBITDA of not less than GBP2.75m for the year ended 31 December 2020.

This strong performance is due to the expansion of our partners internationally, the release of new "Slingo" games, and improvements to the Group's technology. In the second half of the Period, we have gone live with 5 new partners, including PaddyPower Betfair in Europe, and launched 4 new "Slingo" games including Slingo Fluffy Favourites.

The Company has applied for licenses in Pennsylvania and Michigan in the US and hopes to launch in these states during the first half of 2021.